Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Are Pfizer (PFE) and AbbVie (ABBV) Good Value Buys for August?

The pharma industry is poised to witness long-term growth with the introduction of generic medicines and growing demand for personalized and targeted treatments. Hence, fundamentally strong pharma stock AbbVie (ABBV) might be worth buying. However, it might not be the right time to invest in Pfizer (PFE). Keep reading.

StockNews.com

Babies should get new drug that prevents RSV, CDC panel says

A panel of U.S. health advisers is recommending that babies get a new drug to protect them against a respiratory virus

The Independent UK

Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.

The biggest names in Covid are updating their vaccines for a fall campaign, but that might not bolster Pfizer stock and Moderna stock.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer Stock Wavers As Waning Demand For Covid Products Slashes Sales In Half

Pfizer stock wavered early Tuesday after the company reported massive sales and earnings declines amid lower demand for Covid products.

Investors Business Daily

Pfizer Covid Sales Extend Slump, Clouding Q2 Earnings Beat

Slowing Covid treatment sales clipped Pfizer's second quarter revenues, clouding its better-than-expected bottom line beat.

The Street

The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)

Zenger

FDA Violated Own Safety And Efficacy Standards In Approving Covid-19 Vaccines For Children

Evidence the FDA used for those decisions violates at least three safety and efficacy standards from earlier FDA publications

Zenger

Read news from The Economist, FT, and more,
with one subscription

Tornado damage to Pfizer factory highlights vulnerabilities of drug supply

A tornado that ripped through a Pfizer plant in Rocky Mount, N.C., raised worries about shortages of medicines used in hospitals. The drugs include commonly used painkillers and anesthetics.

WEKU

3 Sectors, 3 Unusually Active Put Options to Sell

The markets have been on fire the past couple of weeks. While yesterday’s interest hike took some steam out of the markets, these three stocks and their options are unusually active and worthy of consideration.

Barchart

Is the Rally Getting Long in the Tooth? Try These Bear Call Spread Trades

Traders should have a bearish outlook on the stock and ideally look to enter when the stock has a high implied volatility rank.

Barchart

Pfizer and Moderna parent are investing $100M to find the next big drug

"What we are doing now, I don’t think anyone has done so far," Pfizer CEO Albert Bourla says.

Fortune

Revealed: drug firms funding UK patient groups that lobby for NHS approval of medicines

Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals

The Guardian - UK

Tornado damage to Pfizer plant unlikely to cause major drug supply shortages, FDA says

A tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Anti-vaxxers think God destroyed a Pfizer facility with a tornado

No vaccines were produced or stored at the facility

The Independent UK

Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need

U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week

Zenger

Large Tornado Hits North Carolina, Hospitalizes Several

Interstate 95 Shut Down as Pfizer Facility Suffers Damage

The Guardian - UK

Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’

The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

Zenger

Elderly Nursing Home Residents Denied Life-Saving COVID Treatment, Study Finds

Inadequate use of antiviral medication led to avoidable mortality, with Paxlovid underutilized

Investors Business Daily

Roche Could Take A Page Out Of Merck's Playbook. Why Roivant Surged.

Roche is in discussions to buy a stomach-disease treatment from Roivant for around $7 billion. The report sent ROIV stock surging Friday.

Investors Business Daily

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?

An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.

The Guardian - UK

Panadol maker plans sweeping job cuts a year after being spun off from GSK

Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally

Barchart

Should You Buy the Dip in Pfizer Stock? Here's What You Need to Know

US stock markets delivered stellar returns in the first half of the year and the Nasdaq 100 had its best first-half performance ever. However, Pfizer, whose COVID-19 vaccine made the company a household name recently fell to a 52-week low. Why is Pfizer stock going down and should you buy…

StockNews.com

Should Value Investors Watch Pfizer (PFE)?

Pfizer (PFE) is spending its COVID-19 cash flows on meaningful growth avenues. However, given a recent downgrade, should value investors still be excited about this stock? Let’s look at the trends of its financial metrics to get an idea….

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.